Abacus Global Management: From Life Settlements to the Lifespan-Linked Asset Platform

Uncorrelated, cash-validated, and structurally matched: the interval fund and LifeARC signal a pivot toward fee-based longevity investing.

ABX · Earnings Call · 2026-08-06

The Pivot from Settlement to Platform

Abacus Global Management's Q2 2026 earnings call wasn't just another beat-and-raise. It was a declaration that the company has outgrown its life-settlements origin story. Jay Jackson, Chairman and CEO, framed it starkly: “We are not a traditional asset manager. We are building the infrastructure for lifespan-linked finance.” — Jay Jackson, Chairman and Chief Executive Officer · 2026-08-06 That infrastructure has three pillars now: the Interval Fund (the newly launched ABX Longevity Growth and Income Fund), the LifeARC data/tech platform, and the origination platform that already generates consistent realized gains. The company also surprised the market with asset tokenization—an on-chain record for policy chain-of-title and cash-flow rights—which Jay carefully separated from crypto: "It's a financial infrastructure." Bill McCauley, CFO, quantified the quarter: revenue grew 30% year-over-year to $73 million, with “Abacus grew revenue by 30% over last year to $73 million.” — William McCauley, Chief Financial and Chief Operating Officer · 2026-08-06 Adjusted EBITDA reached $40 million (27% YoY) and adjusted net income of $27.1 million beat the high end of guidance. But the more transformative number is on the balance sheet side: the company deployed $197.9 million of capital and realized average gains of ~25% on policy sales, with book turnover at 2x — all while raising $544 million in longevity fund inflows in H1.

Positioning Against Private Credit Stress

Elena Plesco, CIO, drew a sharp contrast between Abacus and the rest of alternatives. As private credit faces redemption pressure and mark-to-market scrutiny, she argued that mortality-linked assets are effectively immune:

When the concern in the market is whether an asset can be sold at its carried value, we have a book that turns twice a year and tells us the answer in cash.
Elena Plesco, Chief Investment Officer · 2026-08-06

This uncorrelated, cash-validated narrative is the core of the pitch to institutional allocators, and it dovetails with the broader global keyword slate where private credit has been a recurring theme across recent earnings calls. Abacus is deliberately positioning itself as the antidote to the crowded corporate-credit trade. The launch of the interval fund — specifically designed to align investor liquidity with the underlying assets — is the tangible product that operationalizes this philosophy. As Jay noted, it's "not just for retail" — pension funds and RIAs have already shown interest. And the Manning & Napier partnership provides a live referral channel to $18 billion in managed assets, which should accelerate both policy sourcing and LifeARC adoption.

The Numbers Support the Story

The fundamentals, while they lag one quarter behind the call, corroborate the trajectory. Total revenue has grown from $44M in Q1 2025 to $59M in Q1 2026 (the latest 10-Q period). The Q2 call adds another strong step. The Q1 figure of $59M is already ahead of the full-year 2024 average, and the call's $73M for Q2 suggests the growth engine is intact. Operating margin sits at 30.9% (Q1), a healthy level for a firm still ramping investments in technology and distribution. The biggest divergence is in net cash: the company is deeply net-debt (Effective net cash is -$296M, reflecting the capital-hungry policy book, though this is partly offset by non-recourse liabilities and the move toward fee-based fee-related revenue.). This is the key trade-off: the pivot toward asset management is intended to progressively wean the company off balance-sheet deployment and toward recurring fees. Throughout the call, management repeatedly referenced the multi-decade wealth transfer ($124 trillion) as the macro backdrop. It's a familiar but increasingly concrete story, and the company is now attaching real products to it. As Jay said in a previous quarter, "We have a program coming out called LifeArc, which helps us better understand what someone’s mortality distribution curve looks like" (March 2026 call). This quarter, that program moved from concept to revenue with live advisers and a rev-share model. The ambition is clear: “We believe Abacus will become substantially larger based on our current business lines alone.” — Jay Jackson, Chairman and Chief Executive Officer · 2026-08-06 The critical question for investors is execution. The company has shown it can deploy capital and realize gains, but the transition to a fee-based platform depends on scaling the interval fund and LifeARC adoption faster than the interest expense on its net debt. The early signs are strong, but the real test will come in the next two quarters as management transitions guidance to a net basis and the interval fund starts its first full quarter of operations.